Clinical trial Recruiting at 1 site Interventional Ages 14 to 19

Virtual reality program to reduce aggression in young offenders

Official title: Virtual Reality Intervention (VR--GINSO) for Reducing Aggression in Young Offenders

Run by Universidad Francisco de Vitoria · NCT07484919 · Data updated 2026-11-12

This program will test whether adding virtual reality to a four-session intervention helps reduce aggressive behavior in 12–18-year-old juvenile offenders more than the same intervention without VR or their usual treatment.

Quick facts

Study typeInterventional
Ages14 Years to 19 Years
SexAll
Enrollment110 (estimated)
SponsorUniversidad Francisco de Vitoria
Academic / other
Locations1 site (Pozuelo de Alarcón, Cominity of Madrid)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedOctober 26, 2026
Trial IDNCT07484919 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 12–18-year-old youths in residential or custodial settings with recent documented aggressive behavior, fluent in Spanish, and expected to remain in the facility for at least six months.

Probably not a fit

Those with neurological disorders, brain injury, psychiatric conditions that affect cognition or contraindicate VR, or who are not fluent in Spanish (and community-based youth who cannot attend in-person sessions) are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional project compares three groups: usual treatment plus a four-session intervention with virtual reality (VR), the same intervention without VR, and usual treatment only. Participants are 12–18-year-old youth with documented recent aggressive behavior who attend four weekly individual sessions of 1–1.5 hours in addition to their ongoing care. Outcomes include changes in aggressive behavior, anger, impulsivity, emotion regulation, conflict understanding, and related cognitive and physiological markers. The trial is run at Universidad Francisco de Vitoria (Pozuelo de Alarcón, Madrid) using standardized behavioral measures and controlled VR scenarios to see if the VR component provides added benefit.

Why it matters

Potential benefit: If successful, the VR-enhanced program could reduce aggressive incidents and improve emotional control and conflict handling, potentially lowering future reoffending among participating young people.

How similar studies have gone: Previous small studies and pilot programs have used VR for anger management and social skills with promising but preliminary results, so this approach builds on limited prior evidence rather than a large established literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 14-19 years old at the moment of recruitment and allocation.
* Minimum facility stay of 6 months since the begining of the study.
* Documented records of recent aggresive behavior.

Exclusion Criteria:

* Neurological disorder, brain injury, or psyquiatric pathology that affects cognitive functions or advises against use of virtual reality.
* Not being fluent in Spanish.

Where it's running

  • Universidad Francisco de Vitoria
    Pozuelo de Alarcón, Cominity of Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: David Roncero Villarreal, PhD — Universidad Francisco de Vitoria
  • Study coordinator: David Roncero Villarreal, PhD
  • Email: david.roncero@ufv.es
  • Phone: +34 657518370

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.